{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T13:39:07Z","timestamp":1776605947544,"version":"3.51.2"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013003","name":"University of Cagliari","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE00000007"],"award-info":[{"award-number":["PE00000007"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017604","name":"National Institute of Technology Warangal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017604","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012034","name":"Karnatak University Dharwad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bmcl.2026.130534","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:47:21Z","timestamp":1769759241000},"page":"130534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integrated approach to design 5-indolyl-pyrazoles as anti-TB agent"],"prefix":"10.1016","volume":"135","author":[{"given":"K. Mohammed","family":"Zabiulla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabodh","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archakam","family":"Ranganatham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd","family":"Athar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivaraj","family":"Yellappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130534_bb0005","series-title":"Global Tuberculosis Report 2023","year":"2023"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130534_bb0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1590\/S0074-02762005000600001","article-title":"The use of biodiversity as source of new chemical entities against defined molecular targets for treatment of malaria, tuberculosis, and T-cell mediated diseases--a review","volume":"100","author":"Basso","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.bmcl.2026.130534_bb0015","doi-asserted-by":"crossref","unstructured":"Uddin T, Arka JC, Ameer K, BM Redwan MZ, Saikat M, Talha BE, Kuldeep D, et al. Antibiotic resistance in microbes: history, mechanisms, therapeutic strategies and future prospects. J Infect Public Health 2021;14(12): 1750\u20131766.","DOI":"10.1016\/j.jiph.2021.10.020"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130534_bb0020","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.chom.2024.05.015","article-title":"Antibiotic resistance: a key microbial survival mechanism that threatens public health","volume":"32","author":"Abbas","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bmcl.2026.130534_bb0025","series-title":"StatPearls [Internet]","article-title":"Aminoglycosides. [Updated 2023 Jul 17]","author":"Block","year":"2025"},{"issue":"46","key":"10.1016\/j.bmcl.2026.130534_bb0030","article-title":"Mycobacterial aminoglycoside acetyltransferases: a little of drug resistance, and a lot of other roles","volume":"10","author":"Sanz-Garc\u00eda","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2026.130534_bb0035","author":"Padda"},{"issue":"13","key":"10.1016\/j.bmcl.2026.130534_bb0040","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1039\/C4CS00045E","article-title":"Applications of Bartoli indole synthesis","volume":"43","author":"Bartoli","year":"2014","journal-title":"Chem Soc Rev"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130534_bb0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tet.2013.11.051","article-title":"Palladium-catalyzed oxidative C\u2013H bond coupling of indoles and benzaldehydes: a new approach to the synthesis of 3-benzoylindoles","volume":"70","author":"Kianmehr","year":"2014","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2026.130534_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23010134","article-title":"Synthesis and pharmacological activities of pyrazole derivatives: a review","volume":"23","author":"Karrouchi","year":"2018","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130534_bb0055","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1039\/C8MD00055G","article-title":"Triazole\u2013diindolylmethane conjugates as new antitubercular agents: synthesis, bioevaluation, and molecular docking","volume":"9","author":"Danne","year":"2018","journal-title":"MedChemComm"},{"issue":"8","key":"10.1016\/j.bmcl.2026.130534_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12272-013-0242-z","article-title":"Synthesis, antimycobacterial and anticancer activity of novel indole-based thiosemicarbazones","volume":"44","author":"Mashayekhi","year":"2021","journal-title":"Arch Pharm Res"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130534_bb0065","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.bmcl.2015.12.049","article-title":"Synthesis and antituberculosis activity of indole\u2013pyridine derived hydrazides, hydrazide\u2013hydrazones, and thiosemicarbazones","volume":"26","author":"Velezheva","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130534_bb0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.coph.2018.08.001","article-title":"The present state of the tuberculosis drug development pipeline","volume":"42","author":"MDJ","year":"2018","journal-title":"Curr Opin Pharm"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130534_bb0075","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00044-012-0222-8","article-title":"Coumarinyl pyrazole derivatives of INH: promising antimycobacterial agents","volume":"22","author":"Aragade","year":"2013","journal-title":"Med Chem Res"},{"issue":"15","key":"10.1016\/j.bmcl.2026.130534_bb0080","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1016\/j.bmcl.2012.05.063","article-title":"Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives","volume":"22","author":"Pathak","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"24","key":"10.1016\/j.bmcl.2026.130534_bb0085","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1016\/j.bmcl.2016.11.003","article-title":"Discovery of new chemical entities as potential leads against Mycobacterium tuberculosis","volume":"26","author":"Lu","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130534_bb0090","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/acsmedchemlett.5b00176","article-title":"Design, synthesis, and biological evaluation of pyrazolo[1,5-a]pyridine-3-carboxamides as novel antitubercular agents","volume":"6","author":"Tang","year":"2015","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130534_bb0095","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1042\/BST20190950","article-title":"Targeting MmpL3 for anti-tuberculosis drug development","volume":"48","author":"Bolla","year":"2020","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130534_bb0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tibtech.2010.12.006","article-title":"Bacterial cell wall assembly: still an attractive antibacterial target","volume":"29","author":"Bugg","year":"2011","journal-title":"Trends Biotechnol"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130534_bb0105","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.bmc.2017.02.001","article-title":"Mycobacterium tuberculosis chorismate mutase: a potential target for TB","volume":"25","author":"Khanapur","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2026.130534_bb0110","article-title":"The mycobacterial membrane: a novel target space for anti-tubercular drugs","volume":"9","author":"Chen","year":"2018","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130534_bb0115","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0027-2016","article-title":"DNA replication in Mycobacterium tuberculosis","volume":"5","author":"Ditse","year":"2017","journal-title":"Microbiol Spectr"},{"issue":"26","key":"10.1016\/j.bmcl.2026.130534_bb0120","doi-asserted-by":"crossref","first-page":"15497","DOI":"10.1039\/D0RA10728J","article-title":"Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of Mycobacterium tuberculosis and paediatric brain tumour cells","volume":"11","author":"Alsayed","year":"2021","journal-title":"RSC Adv"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130534_bb0125","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s11030-020-10108-z","article-title":"Indole-fused spirochromenes as potential anti-tubercular agents: design, synthesis and in vitro evaluation","volume":"25","author":"Dogamanti","year":"2021","journal-title":"Mol Divers"},{"issue":"61","key":"10.1016\/j.bmcl.2026.130534_bb0130","doi-asserted-by":"crossref","first-page":"32353","DOI":"10.1039\/C4RA04283B","article-title":"L-Proline promoted green and regioselective synthesis of a novel pyrazole based trifluoromethylated fused thiazolopyran scaffold and its biological evaluation","volume":"4","author":"Kalaria","year":"2014","journal-title":"RSC Adv"},{"issue":"34","key":"10.1016\/j.bmcl.2026.130534_bb0135","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1002\/anie.200200553","article-title":"Natural product hybrids as new leads for drug discovery","volume":"42","author":"Tietze","year":"2003","journal-title":"Angew Chem Int Ed"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130534_bb0140","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0968-0896(00)00039-0","article-title":"Synthesis and antitumor activity of some indeno[1,2-b]quinoline-based bis carboxamides","volume":"8","author":"Deady","year":"2000","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130534_bb0145","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/jm0496178","article-title":"Bis-huperzine B: highly potent and selective acetylcholinesterase inhibitors","volume":"48","author":"Feng","year":"2005","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bmcl.2026.130534_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/ajoc.202400165","article-title":"A test case: synthesis and evaluation of 6-(pyrazolyl)-indole hybrid molecules as potential anti-tuberculosis agents","volume":"13","author":"Mohammed Zabiulla","year":"2024","journal-title":"Asian J Org Chem"},{"key":"10.1016\/j.bmcl.2026.130534_bb0155","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejmech.2018.11.032","article-title":"Fluoroquinolone-isatin hybrids and their biological activities","volume":"162","author":"Xu","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"30","key":"10.1016\/j.bmcl.2026.130534_bb0160","doi-asserted-by":"crossref","first-page":"16997","DOI":"10.1039\/C8RA03197E","article-title":"1,2,3-triazole-fused spirochromenes as potential anti-tubercular agents: synthesis and biological evaluation","volume":"8","author":"Ashok","year":"2018","journal-title":"RSC Adv"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130534_bb0165","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bmcl.2014.12.066","article-title":"Synthesis, antimicrobial activity and molecular docking of novel tetracyclic scaffolds incorporating a flavonoid framework with medium sized oxygen heterocycles","volume":"25","author":"Dongamanti","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130534_bb0170","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11030-017-9779-y","article-title":"Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation","volume":"21","author":"Dongamanti","year":"2017","journal-title":"Mol Divers"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130534_bb0175","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1039\/C6MD00593D","article-title":"Design, synthesis, molecular-docking and antimycobacterial evaluation of some novel 1,2,3-triazolyl xanthenones","volume":"8","author":"Goud","year":"2017","journal-title":"MedChemComm"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130534_bb0180","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ejoc.202001484","article-title":"Electrochemical oxidative cyclization: synthesis of polysubstituted pyrrole from enamines","volume":"2021","author":"Chen","year":"2021","journal-title":"Eur J Org Chem"},{"issue":"32","key":"10.1016\/j.bmcl.2026.130534_bb0185","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1016\/j.tetlet.2012.05.148","article-title":"Straightforward copper-catalyzed synthesis of pyrrolopyrazoles from halogenated pyrazolecarbaldehydes","volume":"53","author":"Nayak","year":"2012","journal-title":"Tetrahedron Lett"},{"issue":"14","key":"10.1016\/j.bmcl.2026.130534_bb0190","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1021\/om300464b","article-title":"Pyrazolin-5-ylidene palladium(II) complexes: synthesis, characterization, and application in the direct arylation of pentafluorobenzene","volume":"31","author":"Bernhammer","year":"2012","journal-title":"Organometallics"},{"issue":"19","key":"10.1016\/j.bmcl.2026.130534_bb0195","doi-asserted-by":"crossref","first-page":"18087","DOI":"10.1021\/acsomega.9b01906","article-title":"Synthesis, structural studies, and \u03b1-glucosidase inhibitory, antidiabetic, and antioxidant activities of 2,3-dihydroquinazolin-4(1H)-ones derived from pyrazol-4-carbaldehyde and anilines","volume":"4","author":"Barmak","year":"2019","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130534_bb0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/acs.jcim.9b00918","article-title":"Discovery of new and potent InhA inhibitors as antituberculosis agents: structure-based virtual screening validated by biological assays and X-ray crystallography","volume":"60","author":"Kamsri","year":"2019","journal-title":"J Chem Info Model"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130534_bb0205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00044-019-02293-w","article-title":"New indole and indazole derivatives as potential antimycobacterial agents","volume":"28","author":"Angelova","year":"2019","journal-title":"Med Chem Res"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130534_bb0210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/cmdc.201600020","article-title":"N-Benzyl-4-((heteroaryl) methyl) benzamides: a new class of direct NADH-dependent 2-trans enoyl\u2013acyl carrier protein reductase (InhA) inhibitors with antitubercular activity","volume":"11","author":"Guardia","year":"2016","journal-title":"ChemMedChem"},{"issue":"12","key":"10.1016\/j.bmcl.2026.130534_bb0215","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1021\/jm5005978","article-title":"4-Aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity","volume":"57","author":"Naik","year":"2014","journal-title":"J Med Chem"},{"issue":"21","key":"10.1016\/j.bmcl.2026.130534_bb0220","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/j.bmc.2007.08.013","article-title":"Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides","volume":"15","author":"He","year":"2007","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130534_bb0225","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00044-016-1536-8","article-title":"A convenient synthesis, reactions and biological studies of some novel selenolo[2,3-c]pyrazole compounds as antimicrobial and anti-inflammatory agents","volume":"25","author":"Zaki","year":"2016","journal-title":"Med Chem Res"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130534_bb0230","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1515\/znb-2008-0313","article-title":"Microwave-assisted N-arylation of indoles via C(sp2)\u2013N(sp2) bond formation by aromatic nucleophilic substitution reactions","volume":"63","author":"Xu","year":"2008","journal-title":"Z Naturforsch B"},{"key":"10.1016\/j.bmcl.2026.130534_bb0235","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/9783527637737.ch5","article-title":"Five-membered heterocycles: indole and related systems","author":"Barluenga","year":"2011","journal-title":"Mod Heterocycl Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130534_bb0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s40828-019-0084-5","article-title":"Nucleophilic substitution in nitroarenes: a general corrected mechanism","volume":"5","author":"M\u0105kosza","year":"2019","journal-title":"ChemTexts"},{"issue":"27","key":"10.1016\/j.bmcl.2026.130534_bb0245","doi-asserted-by":"crossref","first-page":"20850","DOI":"10.1074\/jbc.M110.113910","article-title":"Development of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signaling","volume":"285","author":"Jackman","year":"2010","journal-title":"J Bio Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130534_bb0250","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jmb.2006.05.040","article-title":"Probing the mechanism of GSH activation in Schistosoma haematobium glutathione-S-transferase by site-directed mutagenesis and X-ray crystallography","volume":"360","author":"Baiocco","year":"2006","journal-title":"J Mol Bio"},{"issue":"17","key":"10.1016\/j.bmcl.2026.130534_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710102","article-title":"Binding thermodynamics and dissociation kinetics analysis uncover the key structural motifs of phenoxyphenol derivatives as the direct InhA inhibitors and the hotspot residues of InhA","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2026.130534_bb0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.compbiomed.2017.04.003","article-title":"Patient characteristics associated with differences in radiation exposure from pediatric abdomen-pelvis CT scans: a quantile regression analysis","volume":"85","author":"Cooper","year":"2017","journal-title":"Comput Bio Med"},{"issue":"11","key":"10.1016\/j.bmcl.2026.130534_bb0265","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1080\/07391102.2017.1372313","article-title":"Identification of InhA inhibitors: a combination of virtual screening, molecular dynamics simulations and quantum chemical studies","volume":"36","author":"Lone","year":"2018","journal-title":"J Biomol Struct Dyn"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130534_bb0270","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800025","article-title":"Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA","volume":"1","author":"Xia","year":"2018","journal-title":"Life Sci Alliance"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:47:40Z","timestamp":1776602860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"alternative-id":["S0960894X26000016"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130534","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated approach to design 5-indolyl-pyrazoles as anti-TB agent","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130534"}}